In the optimistic version, the businessman who controls a chain of 110 drugstores, all of which located outside Bucharest, says Ropharma revenue could increase by over 20%.
“We usually have two budget variants, a pessimistic one and an optimistic one,” explains Miron, who also developed the Europharm Brasov business from scratch, which it sold to British giant GlaxoSmithKline.
Ropharma is one of the six companies in Transylvania created by Romanian entrepreneurs who managed to see growth rates of over 100% in the last two years, and which were rewarded in early October in Sibiu at the “Business Champions” conference organized by Ziarul Financiar, Enterprise Investors and BCR, with the help of Triple Helix foundation.